ArticleBiologics : targets & therapy2024

Preliminary Investigation and Therapeutic Efficacy Determination of a Novel Anti-IL-17A Antibody, Indikizumab.

Ashok Kumar Patra et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.